Download PDF
Dtsch Med Wochenschr 2015; 140(06): 395-401
DOI: 10.1055/s-0041-100708
Dossier
Herzinsuffizienz
© Georg Thieme Verlag KG Stuttgart · New York

Akute Herzinsuffizienz – eine Sache für sich

Acute heart failure – a unique challenge
Christiane E. Angermann
1   Medizinische Klinik und Poliklinik I, Deutsches Zentrum für Herzinsuffizienz (DZHI), Universitätsklinikum und Universität Würzburg
,
Georg Ertl
2   Medizinischen Klinik und Poliklinik I des Klinikums der Julius-Maximilians-Universität in Würzburg
› Author Affiliations
Further Information

Publication History

Publication Date:
16 March 2015 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Akute Herzinsuffizienz (AHI) ist häufig, lebensbedrohlich, und führt oft zur Hospitalisierung. Leitsymptome sind Luftnot, Ödeme und Fatigue. Ein breites Spektrum von Risikofaktoren, Herzkrankheiten und Komorbiditäten prädisponieren dazu. Typische Auslöser (z. B. Arrhythmien) modulieren das individuelle klinische Bild. Wird es fehlgedeutet, kann das die Diagnose verzögern, die durch kardiale Bildgebung (Echokardiographie) gesichert werden muss. Die Akutbehandlung strebt Symptombesserung und Stabilisierung der Vitalparameter an. Anders als bei chronischer HI gibt es wenig Evidenz für die Wirksamkeit verfügbarer Therapien, Innovationen fehlen hier seit Langem. Der klinische Verlauf geht mit hoher Kurz- und Langzeitmortalität und erneuten Dekompensationen einher. Multidisziplinäre Betreuung ohne Versorgungslücken und bessere Krankheitskompetenz und Selbstüberwachung der Patienten können aber die Prognose bessern. Palliativen Bedürfnissen von AHI-Patienten wird heute noch zu wenig Rechnung getragen.

Abstract

Acute heart failure (AHF) is frequent, often life threatening and followed by emergency hospitalization. Leading symptoms are dyspnea, edema and fatigue. A broad spectrum of risk factors, cardiac diseases and comorbidities predisposes to AHF. Typical triggers (e. g. arrhythmias) modulate the individual clinical picture. Their misinterpretation may delay the diagnosis, which always needs to be ascertained by cardiac imaging (echocardiography). Rescue therapy aims at amelioration of symptoms and stabilization of vital parameters. In contrast to chronic heart failure evidence of the efficacy of available treatments is limited and in the past innovations have been sparse in this area. The clinical course is characterized by high short- and long-term mortality and repeat cardiac decompensations, but seamless multidisciplinary care and better knowledge and self-supervision on the patients’ side might improve prognosis. Today, too little attention is paid to the palliative needs of patients with AHF.

Schlüsselwörter

akute Herzinsuffizienz - Morbidität - Mortalität - Diagnose - Therapie

Keywords

acute heart failure - morbidity - mortality - diagnosis - herapy
 

  • Literatur

  • 1 Lloyd-Jones DM, Larson MG, Leip EP et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002; 106: 3068-3072
    CrossrefPubMedSearch in Google Scholar
  • 2 Stewart S, MacIntyre K, Hole DJ et al. More ‚malignant‘ than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001; 3: 315-322
    CrossrefPubMedSearch in Google Scholar
  • 3 McMurray JJ, Adamopoulos S, Anker SD et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787-1847
    CrossrefPubMedSearch in Google Scholar
  • 4 Gheorghiade M, Zannad F, Sopko G et al. Acute heart failure syndromes: current state and framework for future research. Circulation 2005; 112: 3958-3968
    CrossrefPubMedSearch in Google Scholar
  • 5 Cowie MR, Anker SD, Cleland JGF et al. Improving care for patients with acute heart failure. Before, during and after hospitalization. Oxford: PharmaGenesis; 2014. http://www.oxfordhealthpolicyforum.org/html-version/improving-care-for-patients-with-acute-heart-failure Stand 16. 02. 2015
    Search in Google Scholar
  • 6 Hall MJ, Levant S, DeFrances CJ. Hospitalization for congestive heart failure: United States, 2000–2010. http://www.cdc.gov/nchs/data/databriefs/db108.pdf Stand 16. 02. 2015
  • 7 Cleland JG, Swedberg K, Follath F et al. The EuroHeart Failure Survey programme – a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003; 24: 442-463
    PubMedSearch in Google Scholar
  • 8 Maggioni AP, Dahlström U, Filippatos G et al. Heart Failure Association of ESC (HFA). EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 2010; 12: 1076-1084
    CrossrefPubMedSearch in Google Scholar
  • 9 Neumann T, Biermann J, Erbel R et al. Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int 2009; 106: 269-275
    PubMedSearch in Google Scholar
  • 10 Solomon SD, Dobson J, Pocock S et al. Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Investigators. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 2007; 116: 1482-1487
    CrossrefPubMedSearch in Google Scholar
  • 11 Beckett NS, Peters R, Fletcher AE et al. HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-1898
    CrossrefPubMedSearch in Google Scholar
  • 12 Yusuf S, Sleight P, Pogue J et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 145-153
    CrossrefPubMedSearch in Google Scholar
  • 13 Tavazzi L, Senni M, Metra M et al. IN-HF (Italian Network on Heart Failure) Outcome Investigators. Multicenter prospective observational study on acute and chronic heart failure: one-year follow-up results of IN-HF (Italian Network on Heart Failure) outcome registry. Circ Heart Fail 2013; 6: 473-481
    CrossrefPubMedSearch in Google Scholar
  • 14 Maisel AS, Peacock WF, McMullin N et al. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. J Am Coll Cardiol 2008; 52: 534-450
    CrossrefPubMedSearch in Google Scholar
  • 15 Teerlink JR, Cotter G, Davison BA et al. RELAXin in Acute Heart Failure (RELAX-AHF) Investigators. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 2013; 381: 29-39
    CrossrefPubMedSearch in Google Scholar
  • 16 Wallenborn J, Angermann CE. Comorbid depression in heart failure. Herz 2013; 38: 587-596
    CrossrefPubMedSearch in Google Scholar
  • 17 Angermann CE, Störk S, Gelbrich G et al. Competence Network Heart Failure. Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study. Circ Heart Fail 2012; 5: 25-35
    CrossrefPubMedSearch in Google Scholar